AME - AMETEK, Inc. Pick

Foggy mountains with green slopes and dense forest

Research brief

Nov 03, 2026 Afternoon

06:00 PM UTC

AMETEK, Inc. AME medium

AME

Conf. Medium

Pick Pr. $249.32

Stop Level $245.80

Curr. Pr. $248.58

Change -0.30%

Rem. Days 7

Summary

Selected Pick & Execution Classification: AMETEK, Inc. (NYSE: AME) is selected as an immediate-entry Momentum buy under the authoritative authored research baseline price of $250.665 (timestamped November 3, 2026 at 2:03 PM EST finance.yahoo), with continuous publication monitoring confirming live market execution viability at $249.84 (2:15 PM EST finance.yahoo) and $248.735 (2:43 PM EST). The position operates under a strictly non-extendable 7-day holding horizon ending November 10, 2026 at 18:00:02.405594Z (1:00:02 PM EST).
Core Operating Catalyst: On November 3, 2026 at 06:55 EST, AMETEK reported record third-quarter 2026 financial results: sales increased 17% year-over-year to $2.220 billion (organic sales up 10%), adjusted EPS rose 17% to $2.21, operating margin reached 26.8%, and operating cash flow hit a record $560.6 million with free cash flow of $527.4 million investors.ame. Most crucially, executive disclosures confirmed organic order intake surged +17% (total orders up 35% to a record backlog of $4.54 billion), prompting management to raise full-year 2026 adjusted EPS guidance to $8.53–$8.57 (midpoint $8.55, a calculated 3.64% increase) investors.amefinance.yahoo.
Expected Return & Benchmark Comparison: Under the decider's authoritative authored policy forecast at $250.665, AMETEK delivers an expected absolute net return of +1.313% (net of 0.15% round-trip friction) and an expected excess return of +1.485 percentage points over the matched-horizon SPY benchmark forecast (-0.171% based on SPY at $756.19 finance.yahoo), retaining the top rank among all modeled candidates at -0.115 percentage points of uncertainty-adjusted excess after deducting 1.60 percentage points of diagnostic edge uncertainty. (At the publication execution price of $249.84, expected net return expands to +1.696% and uncertainty-adjusted excess reaches +0.165 percentage points).
Disciplined Execution & Risk Control: Risk is governed by the authoritative authored_stop_ma60_confirm120_hard15_confirm10_tp1p8_v1 policy with an authored stop at $245.80 (below event-session support of $246.46), confirmed via a trailing 60-minute average trading below the stop for 120 minutes (or a 15% hard drop confirmed for 10 minutes). The conditional realized stop exit is conservatively modeled at $244.30 (-2.69% net) to absorb confirmation lag and potential gap slippage, while the full-position profit barrier is placed at 1.8 times the 7-day T1 target return at $269.556 (+7.39% net, versus T1 at the 52-week high of $261.16).
Confidence Assessment: Confidence is assigned as Medium because AMETEK exhibits exceptional organic order momentum, high cash conversion, and clear sector leadership, but the stock has already absorbed approximately 3.6% of intraday repricing matching the guidance increase, trades at a premium valuation (~29.3x FY guidance midpoint), carries post-acquisition leverage ($6.67 billion total debt), and faces broader macro volatility ahead of the U.S. election and major economic prints.

Why Now

AMETEK became actionable before today's market open following its first verified public earnings disclosure on November 3, 2026 at 06:55 EST investors.ame, followed by its 08:30 EST executive conference call finance.yahoo. Third-quarter performance exceeded market expectations across every vital operational dimension: revenue expanded 17% year-over-year to $2.220 billion, driven by 10% organic growth and 7 percentage points of acquisition contribution; adjusted EPS rose 17% to $2.21; and adjusted operating margins expanded to 26.8% investors.amefinance.yahoo. Crucially, demand accelerated dramatically beyond revenue recognition: organic orders grew 17% year-over-year (total orders up 35%), expanding the company's firm order backlog to $4.54 billion finance.yahoo. This high-margin demand velocity gave management the confidence to raise full-year 2026 adjusted EPS guidance from $8.20–$8.30 to $8.53–$8.57, lifting the midpoint by 3.64% from $8.25 to $8.55 investors.ame.

What is Priced In versus the Residual Seven-Day Edge:
Following the pre-market release, AMETEK rallied from its November 2 closing price of $241.91 to an intraday high of $254.48 (+5.20%) before stabilizing around the research freeze price of $250.665 (+3.62% from prior close) and subsequent publication checks at $249.84 finance.yahoo. The initial morning impulse accurately priced in the baseline arithmetic of the headline full-year guidance raise (~3.6%). What remains unpriced—and represents the residual seven-day actionable edge—is the institutional reassessment of AMETEK's underlying demand quality. An organic order acceleration to +17% demonstrates that AMETEK's core electronic instruments and electromechanical niches are experiencing renewed cyclical re-acceleration, defying broader industrial stagnation. Over the remaining 7 days into the November 10 maturity, sell-side analysts will revise forward models, raise price targets, and upwardly re-anchor valuation multiples based on AMETEK's 95%+ cash flow conversion ($527.4 million free cash flow on $508.8 million GAAP net income) and accelerating backlog investors.ame.

Why AME Outperforms Viable Alternatives:
A thorough cross-candidate audit confirms AMETEK offers the cleanest risk-adjusted continuation setup among all reviewed S&P 500 finalists:

Northrop Grumman Corporation (NOC, Final Gate Rank 2): Modeled at $550.665 finance.yahoo. While NOC delivered a solid segment income beat and guidance raise on October 20 investor.nort, its catalyst is two weeks old and already thoroughly absorbed by the market. NOC's rally was subsequently rejected at its $575.55 high, and its free cash flow was flattered by non-operating asset sales, capital proceeds, and pension credits. NOC delivers an expected net return of +0.739% and a negative uncertainty-adjusted SPY excess (-1.290 pp), falling behind AME's top ranking.
Dow Inc. (DOW, Final Gate Rank 3): Modeled at $34.00 finance.yahoo. DOW's October 22 print reflected localized commodity margin stabilization, but overall shipment volumes contracted (-1% YoY) and reported cash flow relied heavily on temporary working-capital reversals investors.dow. DOW barely clears the positive-return hurdle with a negligible expected return of +0.017% and excess return of +0.188 pp, while its wide structural stop ($32.00, -5.9% away) introduces substantial downside risk, yielding an adjusted excess of -1.612 pp.
IDEXX Laboratories, Inc. (IDXX, Final Gate Rank 4): Modeled at $680.48 finance.yahoo. IDXX posted healthy companion-animal diagnostic growth (+11% organic) on November 2 ir.idexx, but the stock surged an astounding +23% over the prior close, far outstripping its modest 0.7% revenue and 1.7% EPS guidance adjustments. Trading at ~45x forward earnings with an intraday base stop at $675.00 that is extremely tight relative to its pre-event ATR of $15.57, IDXX requires a high diagnostic uncertainty allowance of 3.20 pp, leaving its uncertainty-adjusted excess deeply negative at -2.757 pp.
Rollins, Inc. (ROL, Actionable Return-Gate Failure): Modeled at $37.825 finance.yaho. ROL generates a negative expected net return (-0.333%) before uncertainty, failing the mandatory pre-uncertainty absolute return gate. Despite positive sentiment from public share purchases, its underlying Q3 print revealed margin compression (-140 bps) and earnings contraction (-2.9%), rendering it ineligible for allocation.

Business And Market Context

AMETEK, Inc. is a premier global manufacturer of highly differentiated industrial technology solutions, operating through two specialized reporting segments sec.govinvestors.ame:

Electronic Instruments Group (EIG): Designs and manufactures advanced analytical instruments, monitoring equipment, test and calibration devices, and power quality systems for aerospace, defense, laboratory research, medical technology, and power generation. EIG products are deeply embedded into critical client processes, generating predictable aftermarket revenue and high switching barriers.
Electromechanical Group (EMG): Produces precision automation components, engineered electrical interconnects, thermal management subsystems, and specialty metallic alloys for high-reliability medical, automation, and aerospace applications.

AMETEK's competitive moat rests on proprietary engineering know-how, dominant shares in niche markets, and an acquisition strategy (the AMETEK Growth Model) centered on acquiring high-margin, cash-generative technology leaders. The recent acquisition of Indicor closed in Q3 2026, adding complementary industrial instrumentation capabilities and contributing an estimated $0.08 to full-year guidance finance.yahoo.

Macro and Sector Backdrop:
The broader equity market reflects notable bifurcation. The SPY benchmark is priced at $756.19 as of November 3, 2026 at 2:04 PM EST finance.yahoo, exhibiting technical fragility with negative near-term market expectations (-0.171% expected 7-day return) amid rising 10-year Treasury yields, pre-election caution, and impending Non-Farm Payrolls and CPI releases. While mega-cap technology and growth equities have faced aggressive distribution, high-quality industrials (XLI) and defensive compounders have displayed resilient relative strength. AMETEK's strong balance sheet ($666.2 million cash, $2.7 billion total liquidity), robust interest coverage (14.69x operating income to interest), and non-cyclical aerospace/defense/medical customer base position it to withstand broad market churn while outperforming benchmark indices prnewswirefinance.yahoo.

Factor Stack

Evaluating AMETEK through a systematic multi-factor investment framework:

Catalyst & News Quality (High / Bullish): Verified primary earnings release on November 3 at 06:55 EST delivered a comprehensive double-beat and guidance raise investors.ame. Organic orders accelerating +17% represents a high-magnitude leading indicator of fundamental business strength finance.yahoo.
Growth & Operational Quality (Exceptional / Bullish): Q3 net sales of $2.220 billion rose 17% YoY (10% organic), adjusted operating income grew to $595.0 million (26.8% margin), and free cash flow reached $527.4 million (free cash flow conversion exceeded 103% of GAAP net income) investors.ame.
Valuation Setup (Neutral / Stretched): AMETEK trades at a trailing P/E of 36.8x, a vendor forward P/E of 26.4x finance.yahoo, and an entry-to-FY2026 guidance midpoint multiple of 29.3x. While premium multiples reflect superior capital return metrics (ROIC > 15%), this valuation demands near-flawless execution and caps multi-week multiple expansion.
Momentum & Relative Strength (Constructive / Bullish): AMETEK trades at $250.665 (and $249.84 in refreshed trading), firmly above its completed 20-day SMA ($246.90) and 50-day SMA ($243.41) finance.yahoo. Following earnings, AME demonstrated a matched intraday excess return of +3.32 percentage points over SPY and +2.60 percentage points over XLI. Although the stock pulled back from its morning high of $254.48 to trade below session VWAP ($251.21), the pullback has held comfortably above session support ($246.46), forming a constructive post-earnings consolidation shelf.
Estimate Revisions (Strong / Bullish): Management increased full-year adjusted EPS guidance from $8.20–$8.30 to $8.53–$8.57 investors.ame. Independent sell-side consensus estimates are poised to drift higher over the next 3–5 trading days, driving positive institutional order flow into maturity.
Sentiment & Positioning (Clean / Neutral): Short interest is low at 1.81% of float finance.yahoo. Institutional ownership exceeds 85%, and targeted scans of retail and community discussion channels revealed no speculative froth or meme activity. AMETEK is an under-the-radar institutional compounder whose repricing is governed by institutional flows rather than retail speculation.

Investment Thesis

AMETEK represents a compelling 7-day momentum investment driven by a verified operational inflection, superior cash generation, and clear institutional demand persistence:

Order Acceleration Validates Re-acceleration: The standout disclosure in AMETEK's Q3 print is the +17% surge in organic orders, lifting book-to-bill well above 1.0 and expanding firm backlog to $4.54 billion finance.yahoo. In an environment where industrial peers are struggling with destocking and order deferrals, AMETEK's order momentum confirms robust end-market demand across its aerospace and mission-critical electronics franchises.
Superior Cash Generation Underpins Financial Resilience: AMETEK converted 23.8% of third-quarter revenue directly into free cash flow ($527.4 million), driving nine-month operating cash flow to $1.41 billion (+25% YoY) investors.ame. This extraordinary cash generation rapidly deleverages the balance sheet post-Indicor, reducing net debt to 2.1x EBITDA and leaving $2.7 billion in available liquidity to insulate the business against elevated interest rates finance.yahoo.
Structured Technical Path to New Highs: AMETEK's post-announcement price structure established a clear support floor at the event low of $246.46. With the authored stop safely placed at $245.80 (below support), the path of least resistance is upward. The primary resistance level lies at today's high of $254.48 (R1), followed by the October 6 intermediate peak at $255.41. Clearing these obstacles opens the gateway to retesting the 52-week high at $261.16 (the 7-day T1 target), with an 18% probability of extending through that ceiling toward the full-position profit barrier at $269.556 finance.yahoo.

Risks And Thesis Breakers

Despite AMETEK's operational excellence, several distinct risks must be monitored:

Valuation and High Multiple Vulnerability: Trading at ~29.3x full-year guidance, AMETEK possesses minimal buffer against broad-market multiples contraction or unexpected industrial slowdowns.
Indicor Integration and Acquisition Debt: AMETEK holds $6.030 billion in long-term debt and $639.8 million in short-term debt prnewswire. Executive disclosures revealed that approximately $0.08 of the $0.30 guidance midpoint increase was contributed by Indicor finance.yahoo. Any friction in integrating Indicor or unexpected debt refinancing expenses could dampen investor sentiment.
Macro Volatility and Election Churn: The fixed 7-day holding horizon overlaps with the U.S. presidential election, the Federal Reserve's policy meeting, and major inflation releases. A severe risk-off flight could drag industrial equities lower regardless of company-specific fundamental strength.
Execution & Confirmation Gap Risk: Under the policy's 120-minute trailing 60-minute confirmation rule, an adverse opening gap or sudden breakdown cannot be exited instantaneously. If an intraday plunge occurs, the actual realized exit is estimated at $244.30 (or $243.50 in a stressed market) rather than the authored threshold of $245.80, exposing the capital to slippage.

Explicit Thesis Breakers:

A confirmed technical breakdown where AMETEK's 60-minute volume-weighted price remains below the authored stop of $245.80 for 120 minutes, breaking event-day support ($246.46).
Any sudden regulatory investigation, secondary share issuance, or negative executive departure announced before the next stop window.
Unscheduled customer cancellations or material delivery deferrals within the aerospace or defense segments that compromise the $4.54 billion backlog.

Investment Recommendation

Actionable Trade Verdict: BUY AMETEK, Inc. (NYSE: AME) for immediate portfolio inclusion under the authoritative authored research scenario price of $250.665 as of November 3, 2026 at 2:03 PM EST finance.yahoo. Subsequent continuous publication validation confirms live trading execution viability at $249.84 (2:15 PM EST) and $248.735 (2:43 PM EST).

Portfolio Fit and Sizing:
The trade represents a standard single-slot allocation, equivalent to 1/12th (~8.33%) of the fund's total capital. AMETEK cleanly integrates into the existing portfolio without creating concentration breaches. The five active public holdings—BR (1.02 slots, +2.15%), CTSH (0.97 slots, -3.24%), PFE (1.00 slots, +0.07%), STZ (1.04 slots, +3.84%), and XEL (1.00 slots, -0.24%)—occupy business services, IT consulting, pharmaceuticals, consumer beverages, and regulated utilities. AMETEK introduces high-quality industrial technology and precision electronic instruments exposure, enhancing sector diversification while respecting all active-lot restrictions.

Trade Parameters & Exit Architecture:

Entry Price: $250.665 (authored decision freeze quote timestamped November 3, 2026 at 2:03 PM EST) finance.yahoo.
Authored Stop-Loss Price: $245.80 (-1.94% distance), positioned conservatively beneath the verified event-session support level of $246.46.
First Resistance Diagnostic (R1): $254.48 (today's intraday high; secondary resistance at $255.41).
Strategy-Horizon Target (T1): $261.16 (+4.19% return from entry), anchored precisely at the verified 52-week high finance.yahoo.
Full-Position Profit Barrier (B): $269.556 (+7.39% return net of friction). Under the mandatory policy, B is positioned at exactly 1.8 times the T1 percentage return: $250.665 * (1 + 1.8 * ($261.16 - $250.665) / $250.665) = $269.556. Reaching B requires clearing R1 ($254.48), secondary resistance ($255.41), retesting T1 ($261.16), and achieving speculative blue-sky travel into all-time highs.
Execution Policy: authored_stop_ma60_confirm120_hard15_confirm10_tp1p8_v1.
- Normal Stop Confirmation: The position is closed only when the trailing 60-minute average price trades below $245.80 for 120 consecutive minutes.
- Hard Stop Confirmation: An emergency exit is triggered if price drops 15% below entry ($213.065) and confirms for 10 minutes.
- Conditional Realized Stop Exit Price: Modeled at $244.30 (-2.69% net return), incorporating realistic confirmation delay and adverse gap slippage before friction.
- Friction Allowance: 0.15% total round-trip friction applied once (0.10% mandatory adverse exit slippage + 0.05% entry execution spread).
- Post-Exit Cash Treatment: Proceeds from any early stop or profit barrier exit remain held strictly in cash earning zero modeled interest through the remainder of the 7-day period.
Fixed Runtime Maturity: Starts November 3, 2026 at 18:00:02Z; matures strictly on November 10, 2026 at 18:00:02.405594Z (1:00:02 PM EST). Quotes do not extend or reset maturity. If neither the profit barrier nor stop-loss is triggered, the trade concludes via a Time Exit at the first eligible market feed update following maturity, modeled at a conditional terminal price of $254.277 (+1.44% net return).

Scenario Probability Decomposition:

Exit Branch	Price / Level	Net Return	Exclusive Probability	Weighted Return Contribution	Operational Dynamics & Clearance Path
Profit Barrier (B)	$269.556	+7.386%	18%	+1.330%	Requires 60% probability of clearing R1 ($254.48) and T1 ($261.16), multiplied by 30% conditional probability of subsequent speculative new-high expansion to B.
Stop Loss (Realized)	$244.300	-2.689%	27%	-0.726%	Triggered if 60-min MA trades below $245.80 for 120 minutes. Realized price $244.30 reflects confirmation lag and execution slippage below the stop line.
Surviving Time Exit	$254.277	+1.441%	55%	+0.792%	Position survives un-triggered to November 10 maturity; reflects modest upward price drift supported by ongoing sell-side estimate upgrades.
Total / Net Expected	—	—	100%	+1.313%	Expected excess return of +1.485 pp over SPY (-0.171%); uncertainty-adjusted net excess of -0.115 pp (Rank 1).

(Note on Publication Freshness: In continuous publication tracking at the refreshed execution price of $249.84 finance.yahoo and SPY at $755.415 finance.yahoo, the rebased expected net return expands to +1.696%, SPY excess reaches +1.765 pp, and uncertainty-adjusted excess improves to +0.165 pp).

Stress Testing and Sensitivity Analysis:
Under a coherent adverse macro stress scenario—modeling a post-election market selloff where SPY net expected return drops to -0.773% (terminal $751.10), AME profit probability drops to 10%, stop probability increases to 37%, realized stop drops to $243.50, and round-trip friction expands to 0.20%—AMETEK generates an expected net return of -0.219% and an excess return of +0.554 percentage points over the stressed benchmark. The minimum diagnostic uncertainty required to cover this deterioration is 1.532 percentage points, which is fully covered by the declared 1.60 percentage points edge uncertainty. Furthermore, probability-shift headroom analysis indicates that it would require a substantial 13.04 percentage point probability transfer directly from the profit branch to the stop branch before the trade's absolute expected return turns negative, providing robust mathematical cushion.

Comprehensive Candidate Final Gate Comparison Table:

Candidate Symbol	Company Name	Screen Rank	Entry Quote & Timestamp	Authored Stop / Exit Price	7-Day T1 / Profit Barrier B	Expected Net Return (%)	SPY Excess Return (pp)	Declared Uncertainty (pp)	Uncertainty-Adjusted Excess (pp)	Final Gate Rank	Decider Status & Selection Rationale
AME	AMETEK, Inc.	—	$250.665 (Nov 3, 2:03 PM EST) finance.yahoo	$245.80 / $244.30	$261.16 / $269.556	+1.313%	+1.485 pp	1.60 pp	-0.115 pp	1	SELECTED PICK: Freshest double-beat and guidance raise; accelerating organic orders (+17%); highest uncertainty-adjusted excess.
NOC	Northrop Grumman Corporation	6	$550.665 (Nov 3, 2:03 PM EST) finance.yahoo	$539.00 / $530.00	$575.55 / $595.458	+0.739%	+0.910 pp	2.20 pp	-1.290 pp	2	REJECTED FINALIST: Older Oct 20 guidance raise already repriced; prior resistance at $575.55 rejected; lower adjusted excess.
DOW	Dow Inc.	4	$34.000 (Nov 3, 2:04 PM EST) finance.yahoo	$32.00 / $31.65	$36.20 / $37.960	+0.017%	+0.188 pp	1.80 pp	-1.612 pp	3	REJECTED FINALIST: Price-led commodity rebound offset by -1% volume decline; cash flattered by working capital; near-zero net return.
IDXX	IDEXX Laboratories, Inc.	—	$680.480 (Nov 3, 2:03 PM EST) finance.yahoo	$675.00 / $662.00	$700.00 / $715.616	+0.272%	+0.443 pp	3.20 pp	-2.757 pp	4	REJECTED FINALIST: Extreme +23% post-earnings rerating stretches valuation to ~45x forward EPS; wide diagnostic uncertainty (3.2 pp).
ROL	Rollins, Inc.	20	$37.825 (Nov 3, 2:04 PM EST) finance.yaho	$36.15 / $35.50	$39.60 / $41.020	-0.333%	-0.161 pp	2.50 pp	-2.661 pp	5	RETURN GATE FAILURE: Negative expected net return before uncertainty (-0.333%); margin contraction (-140 bps) negates share-purchase momentum.
SPY	SPDR S&P 500 ETF Trust	—	$756.190 (Nov 3, 2:04 PM EST) finance.yahoo	—	—	-0.171%	0.000 pp	—	—	—	BENCHMARK: 7-day expectation reflects growth/tech softness offset by defensive resilience into election and macro data risk.